Related Experiment Videos
Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised
Frank Peters-Klimm1, Stephen Campbell, Katja Hermann
1Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany. frank.peters@med.uni-heidelberg.de
Insights
Case management for chronic heart failure (CHF) by doctors assistants improved self-care and quality of care but did not significantly impact health outcomes or quality of life in this study.
Area of Science:
- Cardiology
- Primary Care Medicine
- Health Services Research
Background:
- Chronic heart failure (CHF) presents a significant burden, necessitating effective interventions.
- Case management is a promising approach for improving patient outcomes in CHF, particularly in primary care settings.
- A new CHF case management model involving doctors' assistants (DAs) and general practitioners (GPs) was evaluated.
Purpose of the Study:
- To explore the effectiveness of a novel CHF case management model.
- To assess the impact of DA-led case management supported by GPs on patient outcomes.
- To evaluate the feasibility of this intervention in primary care practices.
Main Methods:
- A patient-randomised controlled trial (Phase II) involving 31 DAs and GPs across 29 practices.
- Patients with CHF received either 12 months of case management (telephone monitoring, home visits) or usual care.
- Data collected included clinical outcomes, healthcare utilization, and patient-reported quality of life, self-care, and quality of care.
Main Results:
- Baseline adherence to pharmacotherapy and patient self-care were already high.
- Case management (CM) showed significant improvements in CHF self-care (EHFScBS scores) and quality of care (PACIC-5A scores).
- No significant group differences were observed in quality of life (QoL) scores or hospital admission/mortality rates.
Conclusions:
- The case management model demonstrated feasibility and improved key intermediate outcomes like self-care and quality of care.
- In a population with high baseline adherence, the intervention did not lead to significant improvements in overall health outcomes or QoL.
- The study provides evidence for the potential of DA-led case management in CHF care within primary care.
Background:
Chronic (systolic) heart failure (CHF) represents a clinical syndrome with high individual and societal burden of disease. Multifaceted interventions like case management are seen as promising ways of improving patient outcomes, but lack a robust evidence base, especially for primary care. The aim of the study was to explore the effectiveness of a new model of CHF case management conducted by doctors' assistants (DAs, equivalent to a nursing role) and supported by general practitioners (GPs).
Methods:
This patient-randomised controlled trial (phase II) included 31 DAs and employing GPs from 29 small office-based practices in Germany. Patients with CHF received either case management (n = 99) consisting of telephone monitoring and home visits or usual care (n = 100) for 12 months. We obtained clinical data, health care utilisation data, and patient-reported data on generic and disease-specific quality of life (QoL, SF-36 and KCCQ), CHF self-care (EHFScBS) and on quality of care (PACIC-5A). To compare between groups at follow-up, we performed analyses of covariance and logistic regression models.
Results:
Baseline measurement showed high guideline adherence to evidence-based pharmacotherapy and good patient self-care: Patients received angiotensin converting enzyme inhibitors (or angiotensin-2 receptor antagonists) in 93.8% and 95%, and betablockers in 72.2% and 84%, and received both in combination in 68% and 80% of cases respectively. EHFScBS scores (SD) were 25.4 (8.4) and 25.0 (7.1). KCCQ overall summary scores (SD) were 65.4 (22.6) and 64.7 (22.7). We found low hospital admission and mortality rates. EHFScBS scores (-3.6 [-5.7;-1.6]) and PACIC and 5A scores (both 0.5, [0.3;0.7/0.8]) improved in favour of CM but QoL scores showed no significant group differences (Physical/Mental SF-36 summary scores/KCCQ-os [95%CI]: -0.3 [-3.0;2.5]/-0.1 [-3.4;3.1]/1.7 [-3.0;6.4]).
Conclusions:
In this sample, with little room for improvement regarding evidence-based pharmacotherapy and CHF self-care, case management showed no improved health outcomes or health care utilisation. However, case management significantly improved performance and key intermediate outcomes. Our study provides evidence for the feasibility of the case management model.
Trial Registration Number:
ISRCTN30822978.
Related Concept Videos
Heart Failure V: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VI: Adjunct Therapies